Natalie Dean
Asst Professor
Assistant Professor
Faculty, Biostatistics and Bioinformatics
Jointly Appointed, Epidemiology
I am motivated by high-impact quantitative problems in global health. My research focus is on methods to evaluate the effectiveness of interventions targeting emerging infectious diseases, especially vaccines. This includes the use of flexible and model-informed trial frameworks tailored to the outbreak setting, as well as observational study designs such as the test negative design. Prior and ongoing work is in HIV, Ebola, Zika, chikungunya, dengue, and COVID-19. I am co-director of the Emory Alliance for Vaccine Epidemiology (EAVE).
Selected Honors and Awards:
- 2024 - Communications Award, Joint Policy Board of Mathematics
- 2022 - Leadership Academy, Committee of Presidents of Statistical Societies (COPSS)
- 2020 - Provost's Excellence Award for Assistant Professors, University of Florida
Personal Website
Google Scholar Profile
Contact Information
1518 CLIFTON RD
ATLANTA , GA
1518-002
Phone: 4047276124
Fax: 4047271370
Email: nataliedean@emory.edu
Areas of Interest
- Biostatistics
- Clinical Trials
- Global Health
- Immunizations/Vaccines
- Infectious Disease
- Surveillance
- Vaccines
Education
- BA 2009, Boston University
- AM 2011, Harvard University
- PhD 2014, Harvard University
Courses Taught
- BIOS 522: Survival Analysis Methods
Publications
- Amy M Crisp, M Elizabeth Halloran, Ira M Longini, Gonzalo Vazquez-Prokopec, Natalie E Dean, 2023, Covariate-constrained randomization with cluster selection and substitution , Clinical Trials, 20, 284
- Nicolò Gozzi, Matteo Chinazzi, Natalie E Dean, Ira M Longini Jr, M Elizabeth Halloran, Nicola Perra, Alessandro Vespignani, 2023, Estimating the impact of COVID-19 vaccine inequities: a modeling study, Nature Communications, 14, 3272
- Zachary J Madewell, Yang Yang, Ira M Longini, M Elizabeth Halloran, Alessandro Vespignani, Natalie E Dean, 2023, Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants, BMC Infectious Diseases, ,
- Natalie E Dean, David H Howard, Benjamin A Lopman, 2023, Serological Studies and the Value of Information, American Journal of Public Health, 113, 517
- Otavio T Ranzani, Matt DT Hitchings, Rosana Leite de Melo, Giovanny VA de França, Cássia de Fátima R Fernandes, Margaret L Lind, Mario Sergio Scaramuzzini Torres, Daniel Henrique Tsuha, Leticia CS David, Rodrigo FC Said, Maria Almiron, Roberto D de Oliveira, Derek AT Cummings, Natalie E Dean, Jason R Andrews, Albert I Ko, Julio Croda, 2022, Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil, Nature communications, 13, 5536
- Zachary J Madewell, Yang Yang, Ira M Longini, M Elizabeth Halloran, Natalie E Dean, 2022, Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis, JAMA network open, 5, e229317
- Natalie E Dean, M Elizabeth Halloran, 2022, Protecting the herd with vaccination, Science, 375, 1088
- Katia Koelle, Michael A Martin, Rustom Antia, Ben Lopman, Natalie E Dean , 2022, The changing epidemiology of SARS-CoV-2, Science, 375, 1116
- Natalie E Dean, Ira M Longini, 2022, The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks, Clinical Trials, 19, 402
- Matt DT Hitchings, Joseph A Lewnard, Natalie E Dean, Albert I Ko, Otavio T Ranzani, Jason R Andrews, Derek AT Cummings, 2022, Use of recently vaccinated individuals to detect bias in test-negative case–control studies of COVID-19 vaccine effectiveness, Epidemiology (Cambridge, Mass.), 33, 450